Clinical course and outcomes of atrial fibrillation in hypertrophic cardiomyopathy


eMediNexus    27 December 2017

As there is a paucity of clear data on the influence of atrial fibrillation (AF) on clinical course and outcome in hypertrophic cardiomyopathy (HCM), a study published in the Circulation journal was conducted to determine the same. It was suggested that transient symptomatic episodes of AF, often responsible for reduced quality of life, are unpredictable in frequency and timing. However, they are amenable to effective contemporary therapies, and infrequently progress to permanent AF. AF is not considered a major contributor to heart failure morbidity or a cause of arrhythmic sudden death. When treated, it is associated with low disease-related mortality, similar to that for patients without AF. AF is not a common primary cause of death in HCM.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.